Icentia

Company Overview

Icentia is a medical technology company based in Canada. The company specializes in the design and manufacture of innovative medical testing products, particularly in the field of cardiology. Its flagship product, CardioSTAT, is a compact, lightweight, and comfortable ECG recorder designed for long-term continuous ECG monitoring. Icentia operates cardiac diagnostic testing facilities in Canada and the United Kingdom.

CardioSTAT ECG Monitor

CardioSTAT is Icentia's main product, providing long-term continuous ECG monitoring. This compact and lightweight ECG recorder comes in multiple monitoring durations, ranging from 24 hours to 14 days. It has been cleared by the U.S. Food and Drug Administration (FDA) and has been prescribed to over 170,000 patients. CardioSTAT is supported by Icentia's proprietary software, enabling comprehensive data analysis for healthcare institutions and diagnostic facilities.

FDA Clearance for CardioSTAT

The U.S. Food and Drug Administration (FDA) has granted clearance to Icentia's CardioSTAT ECG Monitor. This authorization validates the device's safety and effectiveness for long-term continuous ECG monitoring. FDA clearance is a critical milestone for Icentia, enabling it to provide CardioSTAT to a wider market, including healthcare facilities in the United States.

Market Presence and Innovation

Icentia has established a strong market presence both in Canada and internationally. It has been recognized as one of Canada's Top Growing Companies for four consecutive years by the Globe and Mail. Icentia also provides proprietary software tools that allow healthcare institutions to analyze the data collected by CardioSTAT. This innovative approach to cardiac monitoring has resulted in the largest public single-lead ECG dataset of 11,000 patients, comprising 2 billion annotated beats.

Diagnostic Testing Facilities

Icentia operates diagnostic testing facilities in Canada and the United Kingdom, providing comprehensive cardiac monitoring services. Healthcare institutions benefit from Icentia's in-depth data analysis, enabled by their proprietary software and CardioSTAT ECG monitor. These facilities are integral to the company's mission to advance cardiac diagnostic capabilities and improve patient outcomes.